Cargando…

Comprehensive analysis of UBE2C expression and its potential roles and mechanisms in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) ranks one of the most common and lethal cancers all over the world. Previous studies suggest that ubiquitin-conjugating enzyme E2C (UBE2C) serves as an oncogene in human cancers. However, its expression, diagnosis, prognosis and potential mechanisms in HCC remain large...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao, Ma, Zhaosheng, Mei, Linhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457065/ https://www.ncbi.nlm.nih.gov/pubmed/37580802 http://dx.doi.org/10.18632/aging.204792

Ejemplares similares

A Comprehensive Bioinformatics Analysis of UBE2C in Cancers
por: Dastsooz, Hassan, et al.
Publicado: (2019)

Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databases
por: Wei, Zilun, et al.
Publicado: (2019)

Low-Grade Adenosquamous Carcinoma of the Axilla of Breast Origin in a Male: A Case Report and Literature Review
por: Yan, Xingqiang, et al.
Publicado: (2020)

UBE2C overexpression in melanoma and its essential role in G2/M transition
por: Liu, Guolong, et al.
Publicado: (2019)

UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells
por: Xiong, Yu, et al.
Publicado: (2019)

Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
por: Shao, Xuyang, et al.
Publicado: (2022)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

UBE2T: A new molecular regulator of cancer stemness in hepatocellular carcinoma
por: Leung, Rainbow Wing Hei, et al.
Publicado: (2021)

SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T
por: Tao, Yifeng, et al.
Publicado: (2020)

Contributions of UBE2C and UBE2S to meiotic progression of porcine oocytes
por: FUJIOKA, Yoshie A., et al.
Publicado: (2018)

UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma
por: Liu, Pei-Feng, et al.
Publicado: (2020)

UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma
por: Liu, Li-Li, et al.
Publicado: (2019)

UBE2S promotes cell chemoresistance through PTEN-AKT signaling in hepatocellular carcinoma
por: Gui, Liang, et al.
Publicado: (2021)

Role of UBE2C in Brain Cancer Invasion and Dissemination
por: Domentean, Stefani, et al.
Publicado: (2023)

Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition
por: Zhang, Yan, et al.
Publicado: (2023)

UBE2C promotes malignancy of cutaneous squamous cell carcinoma
por: Luo, Ruiting, et al.
Publicado: (2023)

Diverse roles of UBE2T in cancer (Review)
por: Ma, Nengqian, et al.
Publicado: (2023)

High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression
por: Shen, Zhihua, et al.
Publicado: (2013)

The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression
por: Ho, Nicole Pui Yu, et al.
Publicado: (2021)

The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response
por: Qiu, Lipeng, et al.
Publicado: (2022)

Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis
por: Li, Rong, et al.
Publicado: (2021)

UBE2M promotes cell proliferation via the β-catenin/cyclin D1 signaling in hepatocellular carcinoma
por: Zhang, Guang-Cong, et al.
Publicado: (2020)

From tuberculosis bedside to bench: UBE2B splicing as a potential biomarker and its regulatory mechanism
por: Lyu, Mengyuan, et al.
Publicado: (2023)

The clinical significance of UBE2C gene in progression of renal cell carcinoma
por: Chen, Zhiping, et al.
Publicado: (2021)

UBE3A and Its Link With Autism
por: Vatsa, Naman, et al.
Publicado: (2018)

UBE2J2 promotes hepatocellular carcinoma cell epithelial-mesenchymal transition and invasion in vitro
por: Chen, Shaopeng, et al.
Publicado: (2017)

Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans
por: Landers, Miguel, et al.
Publicado: (2005)

UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Xiaoyuan, et al.
Publicado: (2021)

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
por: Guo, Yanjing, et al.
Publicado: (2023)

The Expression and Role Analysis of Methylation-Regulated Differentially Expressed Gene UBE2C in Pan-Cancer, Especially for HGSOC
por: Li, Jiajia, et al.
Publicado: (2022)

Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma
por: Zhao, Xuemiao, et al.
Publicado: (2021)

Novel neurobiological roles of UBE3A
por: Sun, Jiandong, et al.
Publicado: (2017)

UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival
por: Nousiainen, Ruth, et al.
Publicado: (2023)

Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma
por: Yao, Senbang, et al.
Publicado: (2021)

DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination
por: Zhu, Mengqi, et al.
Publicado: (2021)

UBE2T promotes β‐catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK‐dependent activation
por: Lioulia, Elisavet, et al.
Publicado: (2022)

Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3
por: Alpi, Arno F., et al.
Publicado: (2016)

Integrated Analysis of FAM57A Expression and Its Potential Roles in Hepatocellular Carcinoma
por: Wei, Junwei, et al.
Publicado: (2021)

Comprehensive Analysis of Gene Expression Changes and Validation in Hepatocellular Carcinoma
por: Zhang, Hao, et al.
Publicado: (2021)

Tim-3 expression and its role in hepatocellular carcinoma
por: Liu, Feifei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nn6al0lvnvuuvvj68njb1l9q35